Home 
Today's Top Picks 
Top Performers 
Watchlist 
My Robo Portfolios 
ETF Zone 
How It Works 
News - Chart
- Upturn Summary
- Highlights
- Revenue
- Valuation
Upturn AI Summary - About
Colgate-Palmolive Company(CL)
Advisory History & Simulated Performance *
*as per simulation (see disclosures)- ALL
- 1Y
- 1M
- 1W
- BUY Advisory
- SELL Advisory (Profit)
- SELL Advisory (Loss)
- Profit
- Loss
- PASS (Skip)
Stock price based on last close Advisory Performance History (Simulated)
Upturn Advisory & Investor View for CL
09/25/2026: CL (3-star) is currently NOT-A-BUY. Pass it for now.
Colgate-Palmolive is a premier global consumer products company recognized for its leadership in the oral care and pet nutrition segments. The company's primary strength lies in its iconic brand portfolio and efficient global supply chain, which drive consistent cash flow. Its core growth story centers on the premiumization of the Hill's Pet Nutrition segment and expanding its oral care presence in emerging markets. Investors should monitor risks related to cost inflation, private label competition, and the company's ability to maintain high margins in a volatile environment. As a Dividend King with a defensive profile, it is well-suited for long-term income-oriented investors seeking stability and reliable payout growth.
How to Read the Upturn Advisory
The Upturn Star Rating and the current BUY, SELL, or PASS advisory are generated by Upturn’s AI advisory engine based on proprietary signal analysis, price behavior, advisory history, and historical signal performance.
Company fundamentals, valuation, risks, and news provide supporting context about the business.
Investor Fit
| Investor style | Fit | Why |
|---|---|---|
| Growth investor | Mixed fit | The company offers steady but moderate growth rather than the high-growth potential sought by aggressive investors. |
| Momentum investor | Mixed fit | Momentum fits only during periods of sustained share price upturns linked to strong earnings surprises. |
| Value investor | Mixed fit | It is often fairly valued as a defensive staple, rarely presenting deep-value opportunities. |
| Dividend investor | Strong fit | With over six decades of consecutive dividend increases, it is a hallmark holding for income-focused portfolios. |
| Low-risk investor | Strong fit | The company's defensive business model and consistent performance make it suitable for risk-averse investors. |
Risk Profile
| Risk factor | Level | Why it matters |
|---|---|---|
| Price volatility | Low | As a consumer staple, the stock typically exhibits lower beta compared to the broader market. |
| Valuation risk | Medium | The stock can become expensive during market rotations into defensive assets. |
| Competition risk (consumer staples) | Medium / high | Aggressive pricing from peers and private labels can pressure margins. |
| Business quality | Strong | The company possesses high brand equity and a dominant market position in oral care. |
| Dividend income | Strong | The dividend is highly reliable given the long track record of annual increases. |
| Execution risk | Medium | Maintaining operational efficiency across complex global supply chains is essential for margin protection. |
Price Behavior
Rolling Over
The price momentum is slowing down and beginning to turn downward.
Smooth
The stock has moved along a generally orderly path with only modest fluctuations.
Analysis of Past Performance
Type Stock | Historic Profit 36.89% | Avg. Invested days 84 | Today’s Advisory PASS |
Upturn Advisory Rating  | Upturn Advisory Performance  4.0 | Stock Returns Performance  3.0 |
| Profits based on simulation | Last Close 09/25/2026 |
Upturn Scorecard
Upturn Star Rating 
Company Fundamentals
Financial Health Rating
Growth Momentum Score
Ownership
Top 5 Institutional Investors
Unit Economics (Per $1K Revenue)
Economic Dimensions
Quantitative Style Profile
Style Classification
Quality Focused
Key Highlights
Company Size Large-Cap Stock | Market Capitalization 68.60B USD | Price to earnings Ratio 33.88 | 1Y Target Price 98.8 |
Price to earnings Ratio 33.88 | 1Y Target Price 98.8 | ||
Volume (30-day avg) 4.9M shares | Beta 0.32 | 52 Weeks Range 73.22 - 98.15 | Updated Date 09/27/2026 |
52 Weeks Range 73.22 - 98.15 | Updated Date 09/27/2026 | ||
Dividends yield (FY) 2.45% | Basic EPS (TTM) 2.54 |
How Company Makes Money
| Business area | What it includes | Retail investor read |
|---|---|---|
| Oral Care | Toothpaste, manual and electric toothbrushes, and mouthwash. | The bedrock of the company, providing steady cash flow from daily-use products. |
| Pet Nutrition | Science-led pet food under the Hill's brand. | A high-growth segment leveraging premium demand for pet health. |
| Personal & Home Care | Soaps, deodorants, and surface cleaners. | Consistent, though competitive, segments that stabilize the company's global footprint. |
| Geography | Operations in North America, Latin America, Europe, and Asia/Pacific. | Emerging markets provide long-term growth opportunities, while developed markets provide stability. |
Analyzing Revenue: Products, Geography and Growth
Revenue by Products
Product revenue - Year on Year
Revenue by Geography
Geography revenue - Year on Year
Valuation
Trailing PE 33.88 | Forward PE 20.96 | Enterprise Value 74.99B | Price to Sales(TTM) 3.26 |
Enterprise Value 74.99B | Price to Sales(TTM) 3.26 | ||
Enterprise Value to Revenue 3.56 | Enterprise Value to EBITDA 19.54 | Shares Outstanding 797.17M | Shares Floating 748.35M |
Shares Outstanding 797.17M | Shares Floating 748.35M | ||
Percent Insiders 0.15 | Percent Institutions 86.4 |
Upturn AI Summary
AI Summarization is directionally correct and might not be accurate.
Summarized information shown could be a few years old and not current.
Fundamental Rating based on AI could be based on old data.
AI-generated summaries may have inaccuracies (hallucinations). Please verify the information before taking action.
Financial Metrics
🧭 Investment Snapshot
Total Revenue (Scale)
Total money earned from selling products or services before any costs. It is needed to understand the scale of the business and its ability to generate income.
Net Income (Profit)
Final profit after all expenses, interest, and taxes are deducted. It is needed to determine the overall profitability available to shareholders.
Free Cash Flow (Cash Strength)
Cash remaining after operating activities and capital expenditures, showing cash available for growth. It is needed to evaluate the company’s ability to invest, pay dividends, or reduce debt.
📈 Growth & Strength
Operating Income (Core Profit)
Profit from core operations after deducting all operating expenses. It is needed to measure how efficiently the company runs its primary business activities.
EBITDA (Cash Earnings)
Earnings before interest, taxes, depreciation, and amortization, indicating operating cash potential. It is needed to compare operating performance across companies without accounting or financing differences.
Gross Profit (Unit Profitability)
Revenue minus cost of revenue, showing profit after direct production costs. It is needed to evaluate core business profitability before overhead expenses.
🛡️ Financial Safety
Cash (Liquidity Buffer)
Total cash and cash equivalents on hand. It is needed to evaluate immediate liquidity and financial flexibility.
Total Debt (Leverage Risk)
Total debt including both short-term and long-term components. It is needed to assess the company’s leverage and financial risk.
Net Working Capital (Short-Term Health)
Current assets minus current liabilities, indicating short-term liquidity strength. It is needed to assess whether the company can meet its short-term obligations.
🧱 Balance Sheet Strength
Stockholder Equity (Net Worth)
Total equity value held by shareholders. It is needed to understand the net worth of the company from the owners’ perspective.
Total Assets (Asset Base)
The full value of everything the company owns, including cash, inventory, equipment, and investments. It is needed to understand the resource base used to generate revenue.
Income Before Tax (Pre-Tax Earnings)
Income before provision for income taxes. It is needed to analyze profitability independent of tax structures.
⚙️ Cost & Drag Factors
Cost of Revenue (Production Cost)
Direct costs required to produce and deliver the products or services sold. It is needed to assess efficiency in production and service delivery.
Total Operating Expenses (Operating Cost)
Indirect costs of running the business such as salaries, marketing, and administration. It is needed to understand how much it costs to sustain ongoing business operations.
Income Tax Expense (Tax Drag)
Amount of taxes paid or payable to the government. It is needed to evaluate the impact of taxation on overall profitability.
About Colgate-Palmolive Company
Exchange NYSE | Headquarters New York, NY, United States | ||
IPO Launch date 1977-01-03 | Chairman, CEO & President Mr. Noel R. Wallace | ||
Sector Consumer Defensive | Industry Household & Personal Products | Full time employees 33600 | Website https://www.colgatepalmolive.com |
Full time employees 33600 | Website https://www.colgatepalmolive.com | ||
Colgate-Palmolive Company, together with its subsidiaries, manufactures and sells consumer products in the United States and internationally. It operates through two segments: Oral, Personal and Home Care; and Pet Nutrition. The Oral, Personal and Home Care segment offers toothpaste, toothbrushes, mouthwash, bar and liquid hand soaps, shower gels, shampoos, conditioners, deodorants and antiperspirants, skin health products, dishwashing detergents, fabric conditioners, household cleaners, and other related items. This segment markets and sells its products under the Colgate, Palmolive, Darlie, elmex, hello, meridol, Sorriso, Tom's of Maine, EltaMD, Filorga, Irish Spring, Lady Speed Stick, PCA SKIN, Protex, Sanex, Softsoap, Speed Stick, Ajax, Axion, Fabuloso, Murphy, Soupline, and Suavitel brands to a range of traditional and eCommerce retailers, wholesalers, and distributors, as well as dentists and skin health professionals. It also offers pharmaceutical products for dentists and other oral health professionals. The Pet Nutrition segment offers pet nutrition products for everyday nutritional needs under the Hill's Science Diet brand; and a range of therapeutic pet products to help nutritionally support dogs and cats in different stages of health under the Hill's Prescription Diet brand; and a fresh pet food sold to pet specialty and other retailers in Australia under Prime100 brand. This segment markets and sells its products through pet supply retailers, veterinarians, and eCommerce retailers. Colgate-Palmolive Company was founded in 1806 and is headquartered in New York, New York.
Note: This website is maintained by Upturn Corporation, which is an investment adviser registered with the U.S. Securities and Exchange Commission. Such registration does not imply a certain level of skill or training. Investing in securities has risks. Past performance is no guarantee of future returns. No assurance is provided as to any particular investment return, and you may lose money using our services. You are strongly advised to consult appropriate counsel before making any investments in companies you learn about through our services. You should obtain appropriate legal, tax, investment, accounting, and other advice that takes into account your investment portfolio and overall financial situation. You are solely responsible for conducting due diligence on a potential investment. We do not affect trades for you. You will select your own broker through which to transact. Investments are not FDIC insured, they are not guaranteed, and they may lose value. Please see the Privacy Policy, Terms of Use, and Disclosure for more information.
All company names, trademarks, logos, and brands are the property of their respective owners and are used for identification and informational purposes only. Use of these names, trademarks, and logos does not imply endorsement by their respective owners.